Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;55(8):1348-56.
doi: 10.1093/rheumatology/kev379. Epub 2015 Oct 28.

Motivational interviewing: relevance in the treatment of rheumatoid arthritis?

Sofia Georgopoulou  1 , Louise Prothero  2 , Heidi Lempp  2 , James Galloway  2 , Jackie Sturt  3
Affiliations
Review

Motivational interviewing: relevance in the treatment of rheumatoid arthritis?

Sofia Georgopoulou et al. Rheumatology (Oxford). 2016 Aug.

Abstract

Advances in pharmacological treatment options in RA have led to a dramatic potential for improvement in patients' physical and psychological status. Despite advances, poor outcomes, including fatigue, pain, reduced physical activity and quality of life, are still observed. Reasons include non-adherence to medication, insufficient knowledge about the disease and lack of support in coping and effectively self-managing their condition. Motivational interviewing (MI) is a person-centred approach that relies on collaboration and empathy aiming to elicit a person's own motivation for behaviour change. It has been implemented in a variety of long-term conditions, addressing issues such as lifestyle changes with beneficial effects, but it is yet to be widely recognized and adopted in the field of rheumatology. This review will explain the techniques underpinning MI and the rationale for adopting this approach in rheumatology with the aim to increase medication adherence and physical activity and improve patients' coping strategies for pain and fatigue.

Keywords: intensive management; motivational interviewing; quality of life; remission rates; rheumatoid arthritis.

PubMed Disclaimer

Figures

F<sc>ig.</sc> 1
Fig. 1
Review process of studies using MI in interventions in musculoskeletal and rheumatic diseases
See this image and copyright information in PMC

References

    1. Scott DL, Steer S. The course of established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:943–67. - PubMed
    1. Scott D. Biologics‐based therapy for the treatment of rheumatoid arthritis. Clin Pharmacol Ther 2012;91:30–43. - PubMed
    1. Quinn MA, Conaghan PG, O’Connor PJ. et al. Very early treatment with infliximab in addition to methotrexate in early, poor‐prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve‐month randomized, double‐blind, placebo‐controlled trial. Arthritis Rheum 2005;52:27–35. - PubMed
    1. Wakefield RJ, Freeston JE, Hensor E. et al. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti–tumor necrosis factor medication in early rheumatoid arthritis. Arthritis Care Res 2007;57:1564–7. - PubMed
    1. van der Heijde D, Klareskog L, Landewe R. et al. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 2007;56:3928–39. - PubMed

Publication types